Specifically, we found that in CSF, levels of mitophagy activator PINK1 were significantly reduced in FTLD (both in dementia and MCI stages) compared to AD (dementia and MCI), but did not differ from CU. This evidence concerns the gene PINK1 and Alzheimer disease.